A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults
Completed · Phase 2 · Has a placebo group
Conditions studied: Dengue
In brief
This descriptive study will evaluate the safety and immunogenicity of 5 different formulations of the WRAIR dengue vaccine compared to a placebo.
Key facts
- Study ID
- NCT00239577
- Run by
- GlaxoSmithKline
- People needed
- 86
- Starts
- 2006-04-05
- Expected to finish
- 2007-06-19
- Last updated by the study team
- 2019-02-19
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
Where it is running
- GSK Investigational Site — Silver Spring, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.